Christopher A. Ohl, M.D., Associate Professor Internal Medicine-Infectious Diseases

Christopher A. Ohl, M.D.

Professor, Infectious Diseases

Clinical Specialties

Infectious Diseases, Antimicrobial Utilization and Impact on Clinical Outcomes, Antimicrobial Resistance

Contact Information

Department: 336-716-4395

Insurance Accepted »

Additional Languages

Japanese

Education & Training

M.D., University of Wisconsin Medical School , 1986
B.S., University of Wisconsin-Eau Claire , 1982
Internship, Internal Medicine, National Naval Med Ctr, 1987
Residency, Internal Medicine, National Naval Med Ctr, 1992
Fellowship, Infectious Disease, National Naval Med Ctr, 1994

Memberships

Am Coll Of Physicians
Am Medical Assn
Infectious Disease Society Of

NPI Number

1619952991

Christopher A. Ohl, M.D.

Professor, Infectious Diseases

Contact Information

Academic: 336-716-4507 | Department: 336-716-4395

Recent Publications

Beardsley JR, Williamson JC, Johnson JW, Luther VP, Wrenn RH, Ohl CC. Show me the money: long-term financial impact of an antimicrobial stewardship program. Infect Control Hosp Epidemiol. 2012;33(4):398-400.

Ohl CA, Luther VP. Antimicrobial stewardship for inpatient facilities. J Hosp Med. 2011;6(Suppl 1):S4-S15.

Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis. 2011;53(Suppl 1):S23-S28.

Ohl CA. Infectious arthritis of native joints In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, vol 1. 7th ed. Philadelphia: Churchill Livingstone/Elsevier;2010: 1443-1456.

Luther VP, Bookstaver PB, Ohl CA. Corticosteroids in the treatment of hepatic tuberculosis: case report and review of the literature. Scand J Infect Dis. 2010;42(2):315-317.

Paddock CD, Finley RW, Wright CS, Robinson HN, Schrodt BJ, Lane CC, Ekenna O, Blass MA, Tamminga CL, Ohl CA, et al. Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Infect Control Hosp Epidemiol. 2008;29(Suppl 1):1188-1196.

Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA. Controlling prescription drug expenditures: a report of success. Am J Manag Care. 2007;13(8):473-480.

Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA. Controlling prescription drug expenditures: a case report of success [abstract]. J Gen Intern Med. 2007;22(Suppl 1):64.

Luther VP, Smith ZE, Varela V, Williamson JC, Karchmer TB, Palavecino E, Ohl CA. Risk factors for invasive infection due to cephalosporin resistant enterobacter [abstract]. In: Proceedings of the 17th Annual Meeting of the Society for Healthcare Epidemiology of America; 2007 Apr 14-17; Baltimore (MD). 2007;():a252.5.

Beardsley JR, Williamson JC, Johnson JW, Ohl CA, Karchmer TB, Bowton DL. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest. 2006;130(3):787-793.

Ohl C. Epidemiology of pneumococcal disease and efficacy of polysaccharide vaccines in adults [abstract]. 12th International Conference on Infectious Diseases Abstract Book. 2006;():S232-S233.

Ganatra V, Williamson J, Johnson J, Beardsley J, Karchmer TB, Ohl CA. Improper pre-cision timing of vancomycin prophylaxis in patients undergoing CAG, laminectomy and total joint replacement [abstract]. In: 44th Annual Meeting of the Infectious Diseases Society of America Abstracts; 2006 Oct 12-15; Toronto (Canada). 2006;():85.